SWMCX
Price
$67.09
Change
+$1.01 (+1.53%)
Updated
Dec 20 closing price
VIMAX
Price
$331.89
Change
+$5.20 (+1.59%)
Updated
Dec 20 closing price
Ad is loading...

SWMCX vs VIMAX

Header iconSWMCX vs VIMAX Comparison
Open Charts SWMCX vs VIMAXBanner chart's image
Schwab ® US Mid-Cap Index
Price$67.09
Change+$1.01 (+1.53%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index Admiral
Price$331.89
Change+$5.20 (+1.59%)
VolumeN/A
CapitalizationN/A
SWMCX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
SWMCX vs. VIMAX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SWMCX is a StrongBuy and VIMAX is a Buy.

FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 190B vs. SWMCX (1.66B). VIMAX pays higher dividends than SWMCX: VIMAX (1.49) vs SWMCX (1.37). SWMCX was incepted earlier than VIMAX: SWMCX (7 years) vs VIMAX (23 years). VIMAX is a more actively managed with annual turnover of: 13.00 vs. SWMCX (8.00). SWMCX has a lower initial minimum investment than VIMAX: SWMCX (0) vs VIMAX (3000). VIMAX (16.47) and SWMCX (15.94) have marching annual gain over last year. SWMCX (53.01) and VIMAX (51.69) have equivalent 5 years return.
SWMCXVIMAXSWMCX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD15.11715.45098%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.66B190B1%
Annual Yield % from dividends1.371.4992%
Returns for 1 year15.9416.4797%
Returns for 3 years13.038.11161%
Returns for 5 years53.0151.69103%
Returns for 10 yearsN/A119.36-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDTC2.560.12
+4.92%
CytoMed Therapeutics Limited
AQN4.390.08
+1.86%
Algonquin Power & Utilities Corp
EBAY65.011.06
+1.66%
eBay
DOLE13.70-0.11
-0.80%
Dole plc
BNTC11.41-0.76
-6.24%
Benitec Biopharma